Literature DB >> 35864255

Treat and repeat: oncolytic virus therapy for brain cancer.

John D Christie1, E Antonio Chiocca2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35864255     DOI: 10.1038/s41591-022-01901-4

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   87.241


× No keyword cloud information.
  2 in total

1.  A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma.

Authors:  Tomoki Todo; Yasushi Ino; Hiroshi Ohtsu; Junji Shibahara; Minoru Tanaka
Journal:  Nat Commun       Date:  2022-07-21       Impact factor: 17.694

2.  Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.

Authors:  Tomoki Todo; Hirotaka Ito; Yasushi Ino; Hiroshi Ohtsu; Yasunori Ota; Junji Shibahara; Minoru Tanaka
Journal:  Nat Med       Date:  2022-07-21       Impact factor: 87.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.